Chronic Idiopathic Thrombocytopenic Purpura
Conditions
Brief summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Detailed description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Interventions
DRUGfostamatinib
oral administration
Sponsors
Kissei Pharmaceutical Co., Ltd.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events | 18 months |
Countries
Japan
Contacts
Primary ContactKazunori Abe, director
Outcome results
None listed